Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.980
-0.020 (-0.50%)
At close: Jul 31, 2026, 4:00 PM EDT
3.970
-0.010 (-0.25%)
After-hours: Jul 31, 2026, 7:34 PM EDT

X4 Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.0135.112.56---
Revenue Growth
-71.26%1273.21%----
Gross Profit
7.3829.361.76---
Operating Income
-97.75-86.88-246.4-107.52-88.59-85.11
Net Income
-99.72-79.2-37.45-101.17-91.32-74.75
Earnings Per Share
-3.32-1.87-5.59-17.07-45.60-119.70
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
United States
8.16.52.6
United Kingdom
0.928.6-
Total
935.12.6

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
233.72253102.06114.22121.7281.79
Total Debt
77.2577.2978.0958.2838.4239.79
Net Cash (Debt)
156.47175.7123.9755.9483.342
Net Cash Growth
1656.08%632.93%-57.14%-32.85%98.32%4.33%
Net Cash Per Share
2.174.153.589.4439.3448.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-92.85-85.62-130.9-96.51-77.1-70.91
Capital Expenditures
0--0.33-0.06-0.1-0.62
Free Cash Flow
-92.85-85.62-131.23-96.57-77.21-71.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.82%83.60%68.83%---
Operating Margin
-1084.38%-247.44%-9636.33%---
Pretax Margin
-1106.22%-225.44%-1452.48%---
Profit Margin
-1106.30%-225.56%-1464.61%---
FCF Margin
-1030.05%-243.84%-5132.07%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
41.6510.3649.05---